Newport Beach-based innovation group Octane has introduced a new initiative aimed at speeding up the development of advanced cardiovascular technologies.
The program, called the Mussallem Cardiovascular Accelerator, is designed to help startups working on new solutions for diagnosing, treating, monitoring, and improving care for heart-related conditions.
The launch reflects a growing focus on bridging the gap between early-stage medical innovation and real-world clinical use, particularly in the fast-evolving field of cardiovascular health.
A 14-Week Program Built for High-Impact Startups
The accelerator will run for 14 weeks and is structured to support emerging companies developing breakthrough cardiovascular technologies.
Selected startups will be guided through a structured program focused on strengthening their commercial direction and preparing them for growth.
Participation will be fully virtual, allowing founders from different locations to engage with the program while accessing a wide network of expertise across the healthcare and investment landscape.
Direct Access to Industry Experts and Investors
Startups accepted into the program will receive hands-on support from experienced operators, clinicians, investors, and strategic leaders within the cardiovascular ecosystem.
The goal is to connect founders with the people who can help refine their products, validate clinical relevance, and open doors to funding opportunities.
The curriculum will include applied workshops, executive mentoring sessions, and investor readiness training.
Companies will also benefit from carefully curated introductions to potential partners, advisors, and customers, helping them accelerate both product development and market entry.
Spotlight Opportunity at Major Cardiovascular Forum
As part of the experience, participating startups will be invited to present their technologies at Octane’s Cardiovascular Tech Forum scheduled for September.
At the event, founders will pitch directly to a targeted audience that includes investors, hospital systems, and major global cardiovascular medical device companies.
This showcase is intended to increase visibility for emerging technologies while creating opportunities for funding and strategic partnerships.
Backing From the Mussallem Foundation
The accelerator is supported through a legacy gift from the Linda and Mike Mussallem Foundation.
The foundation has long focused on philanthropic efforts aimed at improving quality of life and advancing healthcare innovation, particularly in areas that can deliver meaningful, long-term patient impact.
Their support underpins the new program’s mission to encourage the development of next-generation cardiovascular solutions.
Octane’s Expanding Innovation Ecosystem
Founded in 2002 and led by Chief Operating Officer Janelle Brunette, Octane has built a reputation as a major accelerator and innovation hub for medical technology and broader tech ventures.
The organization provides an end-to-end support system that helps companies move from early-stage concepts through funding, scaling, and long-term growth.
Through its mix of accelerator programs, investment networks, educational initiatives, and industry events, Octane connects entrepreneurs with the resources needed to grow and compete in global markets.
Strong Track Record in Funding and Job Creation
Over the past decade and more, Octane has played a significant role in supporting the Southern California innovation ecosystem.
Since 2010, the organization has helped 2,514 companies raise more than $12.1 billion in capital.
During the same period, it has also contributed to the creation of 45,237 high-paying jobs, underscoring its broader economic impact alongside its focus on healthcare and technology advancement.
